Improvement in Ventilation-Perfusion Mismatch after Bronchoscopic Lung Volume Reduction: Quantitative Image Analysis

Radiology
Sei Won LeeJoon Beom Seo

Abstract

Purpose To evaluate whether bronchoscopic lung volume reduction (BLVR) increases ventilation and therefore improves ventilation-perfusion (V/Q) mismatch. Materials and Methods All patients provided written informed consent to be included in this study, which was approved by the Institutional Review Board (2013-0368) of Asan Medical Center. The physiologic changes that occurred after BLVR were measured by using xenon-enhanced ventilation and iodine-enhanced perfusion dual-energy computed tomography (CT). Patients with severe emphysema plus hyperinflation who did not respond to usual treatments were eligible. Pulmonary function tests, the 6-minute walking distance (6MWD) test, quality of life assessment, and dual-energy CT were performed at baseline and 3 months after BLVR. The effect of BLVR was assessed with repeated-measures analysis of variance. Results Twenty-one patients were enrolled in this study (median age, 68 years; mean forced expiratory volume in 1 second [FEV1], 0.75 L ± 0.29). After BLVR, FEV1 (P < .001) and 6MWD (P = .002) improved significantly. Despite the reduction in lung volume (-0.39 L ± 0.44), both ventilation per voxel (P < .001) and total ventilation (P = .01) improved after BLVR. However, neither perfusi...Continue Reading

References

Feb 1, 1977·The Journal of Clinical Investigation·P D WagnerJ B West
Apr 25, 1996·The New England Journal of Medicine·F C SciurbaR J Landreneau
Feb 1, 1997·American Journal of Respiratory and Critical Care Medicine·F G Hoppin
Mar 28, 1998·American Journal of Respiratory and Critical Care Medicine·H E Fessler, S Permutt
May 22, 2003·The New England Journal of Medicine·Alfred FishmanUNKNOWN National Emphysema Treatment Trial Research Group
Nov 19, 2003·The European Respiratory Journal. Supplement·P M A Calverley
Jun 29, 2004·The European Respiratory Journal·B R CelliUNKNOWN ATS/ERS Task Force
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Sep 9, 2008·European Journal of Radiology·Sven F ThiemeThorsten R C Johnson
Jun 24, 2010·European Radiology·Sven F ThiemeThorsten R C Johnson
Sep 24, 2010·The New England Journal of Medicine·Frank C SciurbaUNKNOWN VENT Study Research Group
Jan 15, 2011·Journal of Applied Physiology·George CremonaPeter D Wagner
Oct 19, 2011·The European Respiratory Journal·Federico VenutaGiorgio F Coloni
Jan 28, 2012·The European Respiratory Journal·Felix J F HerthUNKNOWN International VENT Study Group
Apr 3, 2012·European Radiology·Matthew S BrownJonathan G Goldin
May 5, 2012·The European Respiratory Journal·Felix J F HerthDirk-Jan Slebos
Jun 14, 2013·European Radiology·Long Jiang ZhangGuang Ming Lu
Jul 13, 2013·The European Respiratory Journal·Arschang ValipourUNKNOWN VENT Study Group
Jan 31, 2015·American Journal of Respiratory and Critical Care Medicine·Maren SchuhmannFelix J F Herth
Jun 28, 2015·European Journal of Radiology·Wolfgang M ThaissKonstantin Nikolaou
Dec 10, 2015·The New England Journal of Medicine·Karin KloosterDirk-Jan Slebos

❮ Previous
Next ❯

Citations

May 31, 2019·Journal of Thoracic Imaging·Alexander S RabinErik E Folch
Jul 5, 2019·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Sei Won LeeSang Min Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.